Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Societal perceptions of women in politics in Cameroon must change
2017-08-30

 Description: Prof Atanga readmore Tags: Prof Lilian Atanga, University of Bamenda, Faculty of Humanities, Centre for Africa Studies, political participation of women 

Prof Lilian Lem Atanga presented a lecture,
Gender, Discourse and Cognition and Implications on
Political Participation, 
as part of the First Humanities
and Gendered Worlds Lecture 2017.
Photo: Charl Devenish


Women have not internalised the fact that they can participate on an equal footing in politics with men. This is one of the conclusions made by Prof Lilian Lem Atanga in a study of the political participation of women in Cameroon.
“There still is a strong belief that women can’t deliver the goods (in areas such as politics),” Prof Atanga said. According to her, stereotypes were still entrenched in Africa and a lot had to be done to change societal perceptions of the role of women in politics.

Poor representation of women in politics
Prof Atanga, an associate professor at the University of Bamenda in Cameroon, was guest speaker at the First Humanities and Gendered Worlds Lecture 2017. The lecture was hosted by the Faculty of Humanities and the Centre for Africa Studies (CAS) at the University of the Free State (UFS) in the Equitas Auditorium, Bloemfontein Campus, on 3 August 2017. The title of the research fellow’s lecture at the CAS lecture was Gender, Discourse and Cognition and Implications on Political Participation.
She noted that although there had been a marked increase in the political participation of women in Cameroon, it still was insufficient. Of the 24 million people in the country, 52% were women but only 20% of the senators and 31% of parliamentarians were women. 

Gender-segregated roles affect participation 
And there are many reasons for this. “A lot more women still believe in gender-segregated roles and this affects their political participation.” Many men also don’t approve of women’s political participation.
In her study Prof Atanga found that stereotypes were also emphasised in the way the media in Cameroon reported on the roles of women. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept